Clinical trial
Metabolic FingerPrinting
NCT05305729 is registered in ClinicalTrials.gov with Arcensus GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolic FingerPrinting
- Lead sponsor
- Arcensus GmbH
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 1, 2021
- Completion date
- March 31, 2026
- Enrollment
- 10,000 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
genetic disease